FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617358006> ?p ?o ?g. }

• W2617358006 endingPage "220" @default.
• W2617358006 startingPage "211" @default.
• W2617358006 abstract "The RADIANT-4 randomized phase 3 study demonstrated significant prolongation of median progression-free survival (PFS) with everolimus compared to placebo (11.0 [95% CI 9.2-13.3] vs. 3.9 [95% CI 3.6-7.4] months) in patients with advanced, progressive, nonfunctional gastrointestinal (GI) and lung neuroendocrine tumors (NET). This analysis specifically evaluated NET patients with GI and unknown primary origin.Patients in the RADIANT-4 trial were randomized 2:1 to everolimus 10 mg/day or placebo. The effect of everolimus on PFS was evaluated in patients with NET of the GI tract or unknown primary site.Of the 302 patients enrolled, 175 had GI NET (everolimus, 118; placebo, 57) and 36 had unknown primary (everolimus, 23; placebo, 13). In the GI subset, the median PFS by central review was 13.1 months (95% CI 9.2-17.3) in the everolimus arm versus 5.4 months (95% CI 3.6-9.3) in the placebo arm; the hazard ratio (HR) was 0.56 (95% CI 0.37-0.84). In the unknown primary patients, the median PFS was 13.6 months (95% CI 4.1-not evaluable) for everolimus versus 7.5 months (95% CI 1.9-18.5) for placebo; the HR was 0.60 (95% CI 0.24-1.51). Everolimus efficacy was also demonstrated in both midgut and non-midgut populations; a 40-46% reduction in the risk of progression or death was reported for patients in the combined GI and unknown primary subgroup. Everolimus had a benefit regardless of prior somatostatin analog therapy.Everolimus showed a clinically meaningful PFS benefit in patients with advanced progressive nonfunctional NET of GI and unknown primary, consistent with the overall RADIANT-4 results, providing an effective new standard treatment option in this patient population and filling an unmet treatment need for these patients." @default.
• W2617358006 created "2017-06-05" @default.
• W2617358006 creator A5003454059 @default.
• W2617358006 creator A5003655999 @default.
• W2617358006 creator A5017947396 @default.
• W2617358006 creator A5020435379 @default.
• W2617358006 creator A5021719278 @default.
• W2617358006 creator A5024263685 @default.
• W2617358006 creator A5025634287 @default.
• W2617358006 creator A5026996845 @default.
• W2617358006 creator A5031648774 @default.
• W2617358006 creator A5035223625 @default.
• W2617358006 creator A5040934952 @default.
• W2617358006 creator A5043534982 @default.
• W2617358006 creator A5046558965 @default.
• W2617358006 creator A5047805603 @default.
• W2617358006 creator A5055143638 @default.
• W2617358006 creator A5059766169 @default.
• W2617358006 creator A5059834800 @default.
• W2617358006 creator A5068503288 @default.
• W2617358006 creator A5079238859 @default.
• W2617358006 creator A5091065205 @default.
• W2617358006 date "2017-05-24" @default.
• W2617358006 modified "2023-10-12" @default.
• W2617358006 title "Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary" @default.
• W2617358006 cites W1586545889 @default.
• W2617358006 cites W1969709966 @default.
• W2617358006 cites W1976471069 @default.
• W2617358006 cites W1982292523 @default.
• W2617358006 cites W1990509102 @default.
• W2617358006 cites W2000520754 @default.
• W2617358006 cites W2001043502 @default.
• W2617358006 cites W2047752632 @default.
• W2617358006 cites W2053825882 @default.
• W2617358006 cites W2060122062 @default.
• W2617358006 cites W2064160785 @default.
• W2617358006 cites W2097126184 @default.
• W2617358006 cites W2099704328 @default.
• W2617358006 cites W2103925127 @default.
• W2617358006 cites W2109398899 @default.
• W2617358006 cites W2112064092 @default.
• W2617358006 cites W2115686439 @default.
• W2617358006 cites W2117589429 @default.
• W2617358006 cites W2135049144 @default.
• W2617358006 cites W2137142564 @default.
• W2617358006 cites W2137775272 @default.
• W2617358006 cites W2138614007 @default.
• W2617358006 cites W2141467520 @default.
• W2617358006 cites W2148430251 @default.
• W2617358006 cites W2148933046 @default.
• W2617358006 cites W2149214723 @default.
• W2617358006 cites W2155644607 @default.
• W2617358006 cites W2160783984 @default.
• W2617358006 cites W2209368665 @default.
• W2617358006 cites W2331022739 @default.
• W2617358006 cites W2573369749 @default.
• W2617358006 doi "https://doi.org/10.1159/000477585" @default.
• W2617358006 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28554173" @default.
• W2617358006 hasPublicationYear "2017" @default.
• W2617358006 type Work @default.
• W2617358006 sameAs 2617358006 @default.
• W2617358006 citedByCount "33" @default.
• W2617358006 countsByYear W26173580062017 @default.
• W2617358006 countsByYear W26173580062018 @default.
• W2617358006 countsByYear W26173580062019 @default.
• W2617358006 countsByYear W26173580062020 @default.
• W2617358006 countsByYear W26173580062021 @default.
• W2617358006 countsByYear W26173580062022 @default.
• W2617358006 countsByYear W26173580062023 @default.
• W2617358006 crossrefType "journal-article" @default.
• W2617358006 hasAuthorship W2617358006A5003454059 @default.
• W2617358006 hasAuthorship W2617358006A5003655999 @default.
• W2617358006 hasAuthorship W2617358006A5017947396 @default.
• W2617358006 hasAuthorship W2617358006A5020435379 @default.
• W2617358006 hasAuthorship W2617358006A5021719278 @default.
• W2617358006 hasAuthorship W2617358006A5024263685 @default.
• W2617358006 hasAuthorship W2617358006A5025634287 @default.
• W2617358006 hasAuthorship W2617358006A5026996845 @default.
• W2617358006 hasAuthorship W2617358006A5031648774 @default.
• W2617358006 hasAuthorship W2617358006A5035223625 @default.
• W2617358006 hasAuthorship W2617358006A5040934952 @default.
• W2617358006 hasAuthorship W2617358006A5043534982 @default.
• W2617358006 hasAuthorship W2617358006A5046558965 @default.
• W2617358006 hasAuthorship W2617358006A5047805603 @default.
• W2617358006 hasAuthorship W2617358006A5055143638 @default.
• W2617358006 hasAuthorship W2617358006A5059766169 @default.
• W2617358006 hasAuthorship W2617358006A5059834800 @default.
• W2617358006 hasAuthorship W2617358006A5068503288 @default.
• W2617358006 hasAuthorship W2617358006A5079238859 @default.
• W2617358006 hasAuthorship W2617358006A5091065205 @default.
• W2617358006 hasBestOaLocation W26173580062 @default.
• W2617358006 hasConcept C126322002 @default.
• W2617358006 hasConcept C141071460 @default.
• W2617358006 hasConcept C142724271 @default.
• W2617358006 hasConcept C168563851 @default.
• W2617358006 hasConcept C203092338 @default.
• W2617358006 hasConcept C204787440 @default.
• W2617358006 hasConcept C207103383 @default.

• next